Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

2,438.45INR
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
Rs2,438.45
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
11,631
52-wk High
Rs2,780.05
52-wk Low
Rs2,201.20

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 8,215.00 8,215.00 8,215.00 --
Year Ending Mar-18 9 30,735.00 32,896.20 29,140.00 33,328.20
Year Ending Mar-19 9 34,503.40 37,704.90 32,596.00 37,976.70
Earnings (per share)
Year Ending Mar-18 9 41.82 49.10 37.49 54.44
Year Ending Mar-19 9 51.06 57.70 40.29 58.39
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 31.10 32.90
P/E High - Last 5 Yrs. -- 40.92 45.97
P/E Low - Last 5 Yrs. -- 23.79 24.37
Beta 0.17 0.90 0.89
Price to Sales (TTM) 14.01 3.98 5.77
Price to Book (MRQ) -- 4.84 5.41
Price to Tangible Book (MRQ) -- 5.66 6.98
Price to Cash Flow (TTM) 174.34 23.02 23.42
% Owned Institutions -- 1.25 2.22

Dividends

  Company industry sector
Dividend Yield 1.24 1.57 1.50
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.33 5.21
Payout Ratio(TTM) 0.00 45.86 43.72

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 3.67 9.24
Sales (TTM) vs TTM 1 Yr. Ago -- 4.72 5.59
Sales - 5 Yr. Growth Rate -- 10.02 10.27
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 16.64 19.65
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.82 10.73
Capital Spending - 5 Yr. Growth Rate -- 15.22 15.19

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.89 2.97
LT Debt to Equity (MRQ) -- 9.91 12.22
Total Debt to Equity (MRQ) -- 13.93 16.52
Interest Coverage (TTM) -- 36.27 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 55.11 54.70
Gross Margin - 5 Yr. Avg. -- 52.40 52.42
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 18.51 10.86
Operating Margin (TTM) 33.89 14.36 4.64
Operating Margin - 5 Yr. Avg. -- 14.42 6.26
Pre-Tax Margin (TTM) 33.89 14.77 5.44
Pre-Tax Margin - 5 Yr. Avg. -- 14.73 6.60
Net Profit Margin (TTM) 23.12 11.05 1.76
Net Profit Margin - 5 Yr. Avg. -- 11.07 2.91
Effective Tax Rate (TTM) 31.77 23.16 23.04
Effective Tax Rate - 5 Yr. Avg. -- 23.41 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 948,737,542 855,667,832
Net Income/Employee (TTM) 718,922 111,622,076 100,655,557
Receivable Turnover (TTM) -- 5.62 5.78
Inventory Turnover (TTM) -- 2.58 3.35
Asset Turnover (TTM) -- 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.45 10.98
Return on Assets - 5 Yr. Avg. -- 12.98 12.37
Return on Investment (TTM) -- 14.90 14.43
Return on Investment - 5 Yr. Avg. -- 16.98 16.18
Return on Equity (TTM) -- 16.41 16.13
Return on Equity - 5 Yr. Avg. -- 18.08 17.47
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 25
13 Week -6.52 -7.86 99 35
26 Week -11.71 -17.56 99 30
52 Week -17.27 -26.91 99 12
YTD -11.53 -25.96 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.41%
# of Holders: 22
Total Shares Held: 9,662,575
3 Mo. Net Change: 100,010
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 3
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.